Siemens Healthineers AG (SHL.DE) Stock

Healthcare · Medical Devices · Member of DAX, TecDAX

Siemens Healthineers AG (SHL.DE) closed at EUR 40.07 on 2026-10-14, a change of -16 % over the past year, with a market capitalization of EUR 45.72B.

Siemens Healthineers AG recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Siemens Healthineers AG key figures

Previous close

EUR 40.07 (2026-10-14)

1-year change

-16 %

Market cap

EUR 45.72B

Enterprise value

EUR 58.25B

P/E ratio (trailing)

19.93

P/E ratio (forward)

17.16

EPS (trailing)

2.05

EPS (forward)

2.38

PEG ratio

1.84

Price to book

2.38

Revenue growth

1.8 %

Earnings growth

22.4 %

Dividend per share (trailing)

1.00

Short ratio

n/a

Employees

74,300

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Siemens Healthineers AG

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS and Novo. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Siemens Healthineers AG and compare it with other stocks.